Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Sorafenib Antitumor Study in Japan
jRCT2080221498Phase 3Completed
- Start
- Jun 2011
- Modality
- Small Molecules
01
Overview
Phase 3 trial of sorafenib in cancer. Started Jun 2011; status: completed.
02
Drugs
sorafenib
03
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080221498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221498.